Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma

This study has been completed.
Information provided by:
Boehringer Ingelheim Identifier:
First received: November 12, 2004
Last updated: October 31, 2013
Last verified: October 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: March 2006 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):